Inventiva is positioned as a high-risk, clinical catalyst play targeting MASH with its oral pan-PPAR

Inventiva (Euronext Paris and NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical

Daix (France), New York City (New York, United States), July 30, 2026 – Update to Press Release Date

Daix (France), New York City (New York, United States), July 29, 2026 – Inventiva (Euronext Paris an

ADAR1 Capital Management LLC decreased its holdings in shares of Inventiva S.A. Sponsored ADR (NASDA

Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and

US stock futures lower with Dow down 500 points. Kura Sushi shares drop after reporting worse-than-e

Daix (France),  New York City (New York, United States), July 2, 2026 – Inventiva (Euronext Paris an

Inventiva (IVA) is technically in oversold territory now, so the heavy selling pressure might have e

Europe's largest independent growth debt fund manager has made an investment through its funds,

Claret Capital Partners participates in €130m financing for Inventiva Inventiva is a clinical biopha

Claret Capital Partners is providing growth funding of €43m as part of Inventiva's €130m debt financ

Daix (France), New York City (New York, United States), June 12, 2026 – Inventiva (Euronext Paris an

The heavy selling pressure might have exhausted for Inventiva (IVA) as it is technically in oversold

US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering t

Daix (France), New York City (New York, United States), June 9,2026 – Inventiva (Euronext Paris and

Secured a new debt financing with funds and accounts managed by BlackRock and Claret Capital Partner

Daix (France), New York City (New York, United States), June 2, 2026 –  Inventiva (Euronext Paris an

Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and

 Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmace

Daix (France), New York City (New York, United States), June 2, 2026 - Inventiva (Euronext Paris and

Daix (France), New York City (New York, United States), le 2 juin 2026 - Inventiva (Euronext Paris e

Daix (France), New York City (New York, United States), May 26, 2026 – Inventiva (Euronext Paris and

Daix (France), New York (United States), May 21, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (

U.S. stock futures rise on Tuesday with Dow futures up 400 points. Phreesia shares fall 26.5% in pre

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst conse

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of pu

Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-mar

Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy

Truist Securities analyst Srikripa Devarakonda initiates coverage on Inventiva (NASDAQ:IVA) with

Barclays analyst Eliana Merle initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rati

Leerink Partners analyst Thomas Smith initiates coverage on Inventiva (NASDAQ:IVA) with a Outperf

Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and lowers the pr

Following the exercise in full of the Underwriters' Option, the total number of ADSs issued in t

Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinica

Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinica

Wolfe Research analyst Steve Fleishman initiates coverage on Inventiva (NASDAQ:IVA) with a Outper